Viatris Inc (VTRS)

Apr 24, 2026

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Apr 24, 2026

Apr 24, 2026

Discipline and Rules-Based Execution in VTRS Response - Stock Traders Daily

Apr 24, 2026

Apr 23, 2026

Viatris Inc. stock rises Thursday, outperforms market - MarketWatch

Apr 23, 2026

Apr 23, 2026

FDA Issues Nationwide Recall of ‘Extended Release’ Xanax for Anxiety - Healthline

Apr 23, 2026

Apr 23, 2026

Taking Xanax XR? FDA Recalls Batch Over Effectiveness Concerns - AOL.com

Apr 23, 2026

Apr 23, 2026

Viatris' Q1 2026 Earnings: What to Expect - Barchart.com

Apr 23, 2026

Apr 22, 2026

Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch

Apr 22, 2026

Apr 20, 2026

Viatris Inc. stock rises Monday, outperforms market - MarketWatch

Apr 20, 2026

Apr 20, 2026

Is Viatris Inc (VTRS) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus

Apr 20, 2026

Apr 20, 2026

Viatris Inc. stock rises Friday, outperforms market - MSN

Apr 20, 2026

Apr 20, 2026

Viatris Inc. (VTRS) Stock Analysis: Navigating Challenges With A 7.10% Potential Upside - DirectorsTalk Interviews

Apr 20, 2026

Apr 20, 2026

Transdermal Skin Patches Market 2026- 2033 Overview: Share, - openPR.com

Apr 20, 2026

Apr 19, 2026

FDA Lists Xanax Recall. Here’s What You Need To Know - Forbes

Apr 19, 2026

Apr 18, 2026

Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know - Yahoo Finance

Apr 18, 2026

Apr 17, 2026

Is Viatris Inc (VTRS) Overvalued After 4.7% Rally? GF Value Says - GuruFocus

Apr 17, 2026

Apr 17, 2026

Xanax recalled nationwide due to potential issue with quality, efficacy - The National News Desk

Apr 17, 2026

Apr 17, 2026

VTRS News | VIATRIS INC (NASDAQ:VTRS) - ChartMill

Apr 17, 2026

Apr 16, 2026

Popular anxiety medication recalled nationwide after FDA warning - NewsNation

Apr 16, 2026

Apr 16, 2026

Xanax XR recalled after discovery that tablets may fail to release medication properly - Fox Business

Apr 16, 2026

Apr 16, 2026

Viatris (VTRS) CCO nets 107,135 shares after RSU and DEU vesting - Stock Titan

Apr 16, 2026

Apr 16, 2026

Why the Xanax recall may not impact your prescription - The Hill

Apr 16, 2026

Apr 15, 2026

Popular Prescription Medication Xanax Is Being Recalled Nationwide - AOL.com

Apr 15, 2026

Apr 15, 2026

Xanax from West Virginia-based company recalled nationwide. What you need to know - Los Angeles Times

Apr 15, 2026

Apr 15, 2026

Xanax bottles recalled nationwide over dissolution issues - WCVB

Apr 15, 2026

Apr 15, 2026

Popular anxiety Xanax drug recalled nationwide: How to check if your prescription is included - nypost.com

Apr 15, 2026

Apr 15, 2026

Xanax, popular anxiety medication, recalled: What to know - FOX 13 Tampa Bay

Apr 15, 2026

Apr 15, 2026

Popular anxiety drug Xanax recalled nationwide: What to know - NBC 5 Chicago

Apr 15, 2026

Apr 15, 2026

Bottles of Xanax, a popular anxiety drug, recalled nationwide. Here’s why - KFOR.com

Apr 15, 2026

Apr 15, 2026

Popular anxiety prescription recalled nationwide - WJHL

Apr 15, 2026

Apr 15, 2026

Bottles of Xanax recalled nationwide. Here’s why - CBS 42

Apr 15, 2026

Apr 14, 2026

Viatris Ophthalmology Data At ASCRS Puts Valuation And Dividend In Focus - Sahm

Apr 14, 2026

Apr 13, 2026

Viatris to Report First Quarter 2026 Financial Results on May 7, 2026 - Lelezard

Apr 13, 2026

Apr 13, 2026

FDA Recalls and Warnings: Potentially Contaminated Cough Drops and Eye Drops, Subpotent Thyroid Medications & More - MedShadow Foundation

Apr 13, 2026

Apr 13, 2026

Behavioral Patterns of VTRS and Institutional Flows - Stock Traders Daily

Apr 13, 2026

Apr 13, 2026

Barclays Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $17 - Moomoo

Apr 13, 2026

Apr 13, 2026

What to watch May 7: Viatris posts Q1 results, holds webcast - Stock Titan

Apr 13, 2026

Apr 10, 2026

Viatris Announces Multiple Data Presentations at ASCRS Annual Meeting - National Today

Apr 10, 2026

Apr 10, 2026

Night Vision Disturbances Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Opus Genetics, Viatris, Nevakar, Vyluma, Pfizer, Allergan, AbbVie - Barchart.com

Apr 10, 2026

Apr 10, 2026

Xanax Has Been Recalled Nationwide, According to a New FDA Report - The Healthy @Reader's Digest

Apr 10, 2026

Apr 10, 2026

Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting - PR Newswire

Apr 10, 2026

Apr 10, 2026

Viatris Announces Launch of Breyna™ (Budesonide and Formoterol Fumarate Dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People With Asthma and Chronic Obstructive Pulmonary Disease, in Partnership With Kind - CSRwire

Apr 10, 2026

Apr 08, 2026

Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch

Apr 08, 2026

Apr 08, 2026

Momentum Shift: Is Viatris Inc impacted by rising ratesWeekly Loss Report & Weekly High Momentum Picks - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Truist Financial Maintains Viatris(VTRS.US) With Buy Rating - Moomoo

Apr 08, 2026

Apr 08, 2026

VTRS INVESTOR NOTICE: Viatris, Inc. Investors with Substantial L - GuruFocus

Apr 08, 2026

Apr 07, 2026

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Apr 07, 2026

Apr 07, 2026

Viagra Maker Blocks Rival's 'Kamagra' TM - Law360

Apr 07, 2026